GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Working Capital/Sales History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Working Capital/Sales(x) | 2.74 | 2.97 | 2.78 | 1.79 | 4.68 |
What is the latest Working Capital/Sales ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Working Capital/Sales |
|---|---|
| Mar2025 | 2.74 |
| Mar2024 | 2.97 |
| Mar2023 | 2.78 |
| Mar2022 | 1.79 |
| Mar2021 | 4.68 |
How is Working Capital/Sales of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Working Capital/Sales | % Change | |
|---|---|---|---|
| Mar2025 | 2.74 | -7.74 | |
| Mar2024 | 2.97 | 6.83 | |
| Mar2023 | 2.78 | 55.31 | |
| Mar2022 | 1.79 | -61.75 | |
| Mar2021 | 4.68 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Working Capital/Sales ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,787.0 Cr | -1.1% | -9.3% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.1% |
-9.3% |
14.5% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses